Neurosense Therapeutics Correlations

NRSN Stock  USD 1.09  0.03  2.68%   
The current 90-days correlation between Neurosense Therapeutics and Neurobo Pharmaceuticals is -0.27 (i.e., Very good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Neurosense Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Neurosense Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Neurosense Therapeutics Correlation With Market

Significant diversification

The correlation between Neurosense Therapeutics and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Neurosense Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurosense Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
To learn how to invest in Neurosense Stock, please use our How to Invest in Neurosense Therapeutics guide.

Moving against Neurosense Stock

  0.49VCYT Veracyte Potential GrowthPairCorr
  0.38VCEL Vericel Corp OrdPairCorr
  0.31A Agilent TechnologiesPairCorr
  0.6KTTAW Pasithea TherapeuticsPairCorr
  0.4VTVT vTv TherapeuticsPairCorr
  0.38DYAI Dyadic InternationalPairCorr
  0.36VTRS ViatrisPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
LGVNREVB
NTRBHILS
NTRBREVB
NTRBNRBO
LGVNQNRX
LGVNNTRB
  
High negative correlations   
RNXTNTRB
RNXTNRBO
RNXTREVB
RNXTLGVN
RNXTHILS
BWVREVB

Risk-Adjusted Indicators

There is a big difference between Neurosense Stock performing well and Neurosense Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Neurosense Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
QNRX  6.71  0.66  0.10  1.48  5.79 
 27.27 
 74.46 
REVB  5.84 (0.43) 0.00  0.44  0.00 
 17.95 
 73.15 
HILS  5.56 (0.58) 0.00 (2.71) 0.00 
 8.33 
 113.15 
NRBO  3.85 (0.33) 0.00  0.83  0.00 
 8.05 
 34.77 
VRAX  7.20  0.86  0.11 (0.31) 6.65 
 21.39 
 70.25 
NTRB  4.11 (0.87) 0.00  1.49  0.00 
 9.76 
 29.61 
LGVN  3.24 (0.15) 0.00 (0.11) 0.00 
 7.27 
 18.33 
RNXT  3.51  0.70  0.15  1.09  3.85 
 8.70 
 27.17 
BWV  3.18  0.31  0.08 (0.46) 2.98 
 4.26 
 68.28 
KPRX  3.14  0.42  0.10  1.47  3.37 
 8.43 
 19.67 

Neurosense Therapeutics Corporate Management